These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7877257)

  • 21. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
    Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 mutations and histological type of invasive breast carcinoma.
    Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M
    Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
    Huynh DP; Pulst SM
    Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.
    Rouleau GA; Merel P; Lutchman M; Sanson M; Zucman J; Marineau C; Hoang-Xuan K; Demczuk S; Desmaze C; Plougastel B
    Nature; 1993 Jun; 363(6429):515-21. PubMed ID: 8379998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL
    Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of ST7 gene alterations in human cancer.
    Dong SM; Sidransky D
    Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational analysis of caspase-14 gene in common carcinomas.
    Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
    Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
    Schmucker B; Ballhausen WG; Kressel M
    Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.
    Chen TC; Hsieh LL; Kuo TT; Ng KF; Wu Chou YH; Jeng LB; Chen MF
    Anticancer Res; 2000; 20(3A):1621-6. PubMed ID: 10928081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma.
    Kleymenova EV; Bianchi AA; Kley N; Pylev LN; Walker CL
    Mol Carcinog; 1997 Jan; 18(1):54-60. PubMed ID: 9022813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
    Sanson M
    Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the BRCA2 gene in hepatocellular carcinomas.
    Katagiri T; Nakamura Y; Miki Y
    Cancer Res; 1996 Oct; 56(20):4575-7. PubMed ID: 8840963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas.
    Yeh SH; Chen PJ; Chen HL; Lai MY; Wang CC; Chen DS
    Cancer Res; 1994 Aug; 54(15):4188-92. PubMed ID: 7913413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.
    Xu L; Sgroi D; Sterner CJ; Beauchamp RL; Pinney DM; Keel S; Ueki K; Rutter JL; Buckler AJ; Louis DN
    Cancer Res; 1994 Oct; 54(20):5262-4. PubMed ID: 7923151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas.
    von Haken MS; White EC; Daneshvar-Shyesther L; Sih S; Choi E; Kalra R; Cogen PH
    Genes Chromosomes Cancer; 1996 Sep; 17(1):37-44. PubMed ID: 8889505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
    Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
    Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
    Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
    Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K
    Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.